Universitätsklinikum Heidelberg: HiDC 2016

Speaker

Francesco Beguinot	University of Naples	Naples	Italy
Neil Docherty	University College Dublin	Dublin	Ireland
Phillipe Froguel	Imperial College London University/ Lille University	London /Lille	UK / France
Anthony Heagerty	University of Manchester	Manchester	UK
Stephan Herzig	Helmholtz Zentrum München, Institute for Diabetes and Cancer	Munich	Germany
Martin Hrabe de Angelis	Helmholtz Zentrum München	Munich/Neuherberg	Germany
Berend Isermann	Otto-von-Guericke-University Magdeburg	Magdeburg	Germany
Rohit N Kulkarni	Harvard Medical School	Boston	USA
George Kunos	National Institutes of Health (NIH) - NIAAA	Bethesda	USA
Tony Lam	Toronto General Research Institute and Department of Medicine	Toronto	Canada
Susanne Mandrup	University of Southern Denmark	Odense	Denmark
Alexander Pfeifer	University of Bonn	Bonn	Germany
Michael Potente	Max Planck Institute for Heart and Lung Research	Bad Nauheim	Germany
Matthew Poy	Max-Delbrück-Center for Molecular Medicine (MDC)	Berlin	Germany
Michael Ristow	ETH Zurich	Zurich	Switzerland
Alan Saltiel	University of California	La Jolla	USA
Aurelio Teleman	German Cancer Research Center (DKFZ)	Heidelberg	Germany
Frederic Tessier	Lille 2 University	Lille	France
Paul Thornalley	University of Warwick	Coventry	UK
Emmanuel van Obberghen	University of Nice	Nice	France
Erwin Wagner	CNIO - Centro Nacional de Investigaciones Oncologicas	Madrid	Spain
Siu Ling Wong	Harvard Medical School	Boston	USA
Giles Yeo	University of Cambridge	Cambridge	UK

Program

08.00 - 08.50	Registration
08.50	Welcome Stephan Herzig, Helmholtz Zentrum München, Institute for Diabetes and Cancer, Munich
09.00 - 12.30	Session I: Novel concepts derived from clinical studies
09.00	Essential role of peripheral cannabinoid-1 receptors in type-2 diabetes and diabetic nephropathy George Kunos, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda
09.30	Prenatal environment and diabetes: possible role of microRNAs Emmanuel Van Obberghen, Department of Medical Research IRCAN Medical School, Nice
10.00	Inflammatory links between obesity and diabetes Alan Saltiel, UC San Diego Institute for Diabetes and Metabolic Health (IDMH), La Jolla
10.30	Coffee break
11.00	Using iPS cells to interrogate diabetes complications Rohit N Kulkarni, Joslin Diabetes Center- Harvard Medical School, Boston
11.30	Targeting BAT as a new approach to tackle diabetes Alexander Pfeifer, University of Bonn, Bonn
12.00 - 12.30	Short Talks I
12.00	Reduced glyoxalase 1 activity in carotid artery plaques of non-diabetic patients with increased HbA1c Andreas Peters, University of Heidelberg, Heidelberg
12.15	Impact of the glyoxalase system on organ development and function under diabetic conditions in zebrafish Elisabeth Lodd, Medical Faculty Mannheim, Heidelberg University, Mannheim
12.30 - 14.30	Lunch break and poster session Posters are displayed in Foyer
14.30 - 18.00	Session II: Genetics and Epigenetics of diabetic complications
14.30	Genetic susceptibility to diabetes Philippe Froguel, Imperial College London, London/ Lille University, Lille
15.00	New Genetic and Epigenetic insights into Metabolism and Diabetes Martin Hrabe de Angelis, Helmholtz Zentrum München, Institute of Experimental Genetics, Munich/ Neuherberg
15.30	Genetics of obesity: Can an old dog teach us new tricks? Giles Yeo, University of Cambridge, Cambridge
16.00	Coffee break
16.30	Transcriptional networks regulation adipocyte differentiation and function Susanne Mandrup, University of Southern Denmark, Odense
17.00	The regulatory role of Argonaute2 in glucose and lipid metabolism Matthew Poy, Max Delbrueck Center for Molecular Medicine, Berlin
17.30 - 18.00	Short Talks II
17.30	Transforming Growth Factor Beta-like stimulated clone 22 D4 promotes diabetic hyperglycemia and insulin resistance Bilgen E. Uestuenel, Heidelberg – IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg
17.45	Crosstalk of fatty liver with renal sinus fat impairs renal function and glomerular cell integrity Erwin Schleicher, University of Tuebingen, Tuebingen
18.00	End of Session

08.00 - 08.50	Registration
09.00 - 12.30	Session III: Emerging concepts in vascular dysfunction
09.00	Regulation of endothelial quiescence by metabolites Michael Potente, Max Planck Institute for Heart and Lung Research, Bad Nauheim
09.30	Delayed wound healing in diabetes: The impact of NETs Siu Ling Wong, Harvard Medical School, Boston
10.00	Perivascular Adipose Tissue and Arterial Function in Health and Obesity Anthony Heagerty, University of Manchester , Manchester
10.30	Coffee break
11.00	Metabolic Stress in the Control of Healthspan Michael Ristow, ETH Zurich, Zurich
11.30	Proteostasis in diabetic nephropathy Berend Isermann, Otto-von-Guericke-University Magdeburg, Magdeburg
12.00 - 12.30	Short Talks III
12.00	Vascular complications associated with gestational diabetic mothers and their newborn Halime Kenar, Kocaeli University, Kocaeli
12.15	Oxidative stress and biochemical markers of vascular disease in Type 1 diabetes mellitus Jan Skrha, Charles University, Prague
12.30 - 14.30	Lunch break and poster session Posters are displayed in Foyer
14.30 - 16.00	Session IV: Organ-Metabolism Crosstalk
14.30	Impaired methylglyoxal detoxification recapitulates progression of Type 2 Diabetes Aurelio Teleman, German Cancer Research Center (DKFZ), Heidelberg
15.00	Brain-Liver Axis Tony Lam, Toronto General Research Institute (TGRI), Toronto
15.30	Inflammation and metabolic dysfunction Erwin Wagner, Spanish National Cancer Research Center, Madrid
16.00	End of Sessions
16.00 – 16.30	Coffee break
16.30 – 17.00	EASD Business Meeting

08.00 - 08.50	Registration
09.00 - 12.30	Session V: EASD
09.00	Glyoxalase 1 inducers - a new treatment for diabetic complications? Paul Thornalley, University of Warwick, Coventry
09.30	The liver as a regulator of diabetic complications Stephan Herzig, Helmholtz Zentrum München, Institute for Diabetes and Cancer, Munich
10.00	Effect of Gastric Bypass Surgery on Experimental Diabetic Kidney Disease Neil Docherty, University College Dublin, Dublin
10.30 - 11.00	Short Talk EASD
	Dicarbonyl stress in periodontitis – the fifth complication of diabetes Naila Rabbani, University of Warwick, Coventry
10.45 - 11.00	Coffee break
10.30 - 11.30	Poster Session EASD Posters are displayed in Foyer
11.30	AGEs, can we eat diabetes? Frederic Tessier, Lille 2 University, Lille
12.00	Does Epigenetics account for Diabetes (and Comorbidity) Risk? Francesco Beguinot, Federico II University of Naples, Naples
12.30 - 13.30	Farewell